These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15219534)

  • 1. Angiotensin-converting enzyme inhibitor meta-analysis provides misleading conclusion.
    Mills E; Montori VM; Thabane L
    Am J Cardiol; 2004 Jul; 94(1):149. PubMed ID: 15219534
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitors in congestive heart failure.
    Norcross WA
    West J Med; 1995 Jul; 163(1):67. PubMed ID: 7667987
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of congestive heart failure in high risk patients.
    Wachtell K
    Eur Heart J; 2009 Mar; 30(6):638-9. PubMed ID: 19240069
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of handgrip stress test for evaluation of cilasapril treatment in patients with heart failure.
    Kurita A; Takase B
    Anadolu Kardiyol Derg; 2003 Jun; 3(2):184; author reply 185. PubMed ID: 12826519
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension: which drugs to choose for patients with cardiovascular disease.
    Wexler R; Feldman D
    J Fam Pract; 2006 Apr; 55(4):291-8. PubMed ID: 16608667
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitors in concomitant heart failure and depression.
    Parashar A; Varma A
    J Am Geriatr Soc; 2007 Aug; 55(8):1303; author reply 1303-4. PubMed ID: 17661975
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic strategies of heart failure due to hypertension].
    Kihara Y; Sasayama S
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():312-5. PubMed ID: 11028347
    [No Abstract]   [Full Text] [Related]  

  • 10. Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension.
    Schellenbaum GD; Smith NL; Heckbert SR; Lumley T; Rea TD; Furberg CD; Lyles MF; Psaty BM
    J Am Geriatr Soc; 2005 Nov; 53(11):1996-2000. PubMed ID: 16274385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How to prescribe converting enzyme inhibitors].
    Castaigne A; Duval-Moulin AM; Dubois-Rande JL
    Rev Prat; 1988 Mar; 38(10):626-30. PubMed ID: 3375764
    [No Abstract]   [Full Text] [Related]  

  • 12. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA; Movahed A
    Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, or both in chronic heart failure.
    Young JB
    Heart Fail Clin; 2005 Apr; 1(1):39-47. PubMed ID: 17386832
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiotensin-converting enzyme inhibitors. Principles and rules of use].
    Pham I; Michel JB
    Rev Prat; 1995 Feb; 45(3):373-6. PubMed ID: 7725043
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
    Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
    Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
    Epstein BJ; Gums JG
    Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the drug treatment of hypertension in patients with cardiovascular disease.
    White WB
    Am J Med; 2005 Jul; 118(7):695-705. PubMed ID: 15989899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ACE inhibitor or ATII receptor blocker in heart failure and myocardial infarction?].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):38-40. PubMed ID: 15643463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are angiotensin-receptor blockers (ARBs) equivalent to or better than angiotensin-converting enzyme (ACE) inhibitors in the treatment of heart failure?
    Reigle J
    Crit Care Nurse; 2004 Dec; 24(6):67-9. PubMed ID: 15646090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.